BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18988753)

  • 1. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study.
    Mueller T; Dieplinger B; Poelz W; Endler G; Wagner OF; Haltmayer M
    Clin Chem; 2009 Jan; 55(1):68-77. PubMed ID: 18988753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study.
    Dieplinger B; Haltmayer M; Poelz W; Mueller T
    Clin Chim Acta; 2009 Oct; 408(1-2):87-91. PubMed ID: 19646980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
    PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Dieplinger B; Forstner T; Poelz W; Haltmayer M
    Clin Chem Lab Med; 2010 Apr; 48(4):537-42. PubMed ID: 20148724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
    Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis.
    Wei XB; Liu YH; He PC; Yu DQ; Zhou YL; Tan N; Chen JY
    Eur J Prev Cardiol; 2017 May; 24(7):676-684. PubMed ID: 28067531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R; Allison MA; Criqui MH
    J Am Coll Cardiol; 2007 Jun; 49(22):2172-81. PubMed ID: 17543637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
    Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
    J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide.
    Nordling P; Kiviniemi T; Strandberg M; Strandberg N; Airaksinen J
    BMJ Open; 2016 Feb; 6(2):e009416. PubMed ID: 26911583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
    Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I
    Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
    Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
    [No Abstract]   [Full Text] [Related]  

  • 14. N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients.
    Satoh A; Doi S; Naito T; Nakashima A; Masaki T
    Clin Exp Nephrol; 2021 Oct; 25(10):1142-1150. PubMed ID: 34106372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [N-terminal pro-B-type natriuretic peptide value for prediction of mortality among critically ill patients in different age groups in intensive care unit].
    Li H; Wang H; Lou Y; Miao W; Sha N
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):508-12. PubMed ID: 25027431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
    Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
    Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease.
    Popelová JR; Kotaška K; Tomková M; Tomek J
    Am J Cardiol; 2015 Nov; 116(9):1425-30. PubMed ID: 26404943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.